ToMORROW prescription antibiotic has been depended on by generations of producers. View this piece for even more reasons to choose ToMORROW.
ToMORROW®
(cephapirin benzathine)
Dry cow mastitis treatment
(cephapirin benzathine)
Details
ToMORROW prescription intramammary antibiotic gives dairy producers time-tested, broad-spectrum control against the harmful organisms that cause mastitis in dry cows.
-
ToMORROW has been an effective prolonged therapy treatment for more than 25 years.
-
ToMORROW has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows when caused by Streptococcus agalactiae and Staphylococcus aureus, including penicillin-resistant strains.
-
ToMORROW is formulated with cephapirin benzathine to provide broad-spectrum and long-acting therapy that dry cows need.
Features & Benefits
TOP REASONS TO USE ToMORROW® (cephapirin benzathine)
-
Targets the most common bacteria at dry-off
ToMORROW prescription intramammary antibiotic effectively targets and controls Gram-positive organisms, which represent 94% of infections that occur during dry-off.1 -
Equally effective as the competition
In a head-to-head study, ToMORROW antibiotic was found to be equally as effective as Spectramast® DC (ceftiofur hydrochloride) and Quartermaster® (penicillin-dihydrostreptomycin in oil) in bacteriological cure.1 -
Shorter milk and slaughter withhold
Milk withhold: 72 hours versus 96 hours post calving for QUARTERMASTER, which means you can put your cows back into production sooner.
Slaughter withhold: 42 days versus 60 days + 96 hours after the last infusion allows you to market 22 days sooner. -
Opti-Sert® reduces new infections
The Opti-Sert® tip reduces new mastitis infections by up to 50%,2 and makes partial insertion easier.
Dosage & Administration
Presentations
-
Pail containing 144 x 10-mL syringes and 144 convenient single-use alcohol pads.
-
Cartons containing 12 x 10-mL syringes with 12 convenient single-use alcohol pads.
Partial insertion reduces new infections
-
With the Opti-Sert® applicator tip, partial insertion reduces the incidence of new infections during the dry period.2
-
Studies have shown that when infusing into the udder at a depth of 2 to 3 millimeters, as opposed to 5 or more millimeters, new intramammary infections can be reduced by as much as 50 percent.2
Dosage Information
-
Infuse a 10-mL syringe (300 mg cephapirin activity per syringe) after each quarter has been completely milked out.
Additional Administration Information:
Resources
Product Inserts & Labels
Safety
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Safety Information
ToMORROW should be administered with caution to subjects which have demonstrated some form of allergy, particularly to penicillin. Such reactions are rare; however, should they occur, consult your veterinarian.
Residue Warnings
-
For use in dry cows only.
-
Not to be used within 30 days of calving.
-
Milk from treated cows must not be used for food during the first 72 hours after calving.
-
Any animal infused with this product must not be slaughtered for food until 42 days after the latest infusion.
References
1 Arruda AG, Godden S, Rapnicki P, et al. Randomized non-inferiority clinical trial evaluating three commercial dry cow mastitis preparations: I. Quarter-level outcomes. J Dairy Sci 2013;96(7):44419–4435.
2 Sutherland SF. Novel syringe partial infusion, in Proceedings. National Mastitis Council 1989.
Trademarks
ToMORROW® is a registered trademark of Boehringer Ingelheim Animal Health USA Inc. All other trademarks are the property of their respective owner. ©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved.
US-BOV-0393-2021-V2